Mariner Wealth Advisors (NYC)’s Novo Nordisk NVO Stock Holding History

Mariner Wealth Advisors (NYC)’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	$122K	Buy	+4,566	New	+$105K	0.06%	94

Other funds holding NVO

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $42.5B AUM 18.19% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Mariner Wealth Advisors (NYC)'s NVO Position: Q1 2015 in Review

Mariner Wealth Advisors (NYC) opened a new position in Novo Nordisk (NVO) in Q1 2015: 4,566 shares worth $122K. The stake represents 0.06% of the portfolio and ranks #94 among its holdings.

506 funds tracked by Wall St. Rank hold NVO as of Q1 2015.

Mariner Wealth Advisors (NYC) held 4,566 shares of Novo Nordisk worth $122K as of Q1 2015.
Novo Nordisk was a new Mariner Wealth Advisors (NYC) position in Q1 2015.
Novo Nordisk made up 0.06% of Mariner Wealth Advisors (NYC)'s portfolio in Q1 2015, its #94 holding.
506 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2015.

Based on Mariner Wealth Advisors (NYC)'s 13F filing for Q1 2015, filed 14 May 2015.